Close

Katherine Atkins

BSc MRes PhD

Associate Professor
of Infectious Disease Modelling

Room
104

LSHTM
Keppel Street
London
WC1E 7HT
United Kingdom

2013-2014 Associate Research Scientist, Yale University (School of Public Health)

2010-2013 Postdoctoral Associate, Yale University (School of Public Health)

2006-2010 PhD, University of Edinburgh (Biology)

2005-2006 MRes, University of York (Mathematical Biology)

2000-2004 BSc, University of Edinburgh (Mathematics)

Affiliations

Department of Infectious Disease Epidemiology
Faculty of Epidemiology and Population Health

Centres

Centre for the Mathematical Modelling of Infectious Diseases (CMMID)
Vaccine Centre

Teaching

Introduction to Infectious Disease Modelling (MSc)
Introduction to Infectious Disease Modelling (Short Course) 

Research

Research Area
Economic evaluation
Health policy
Infectious disease policy
Public health
Trypanosomes
Vaccines
Disease control
Immunisation
Vector control
Modelling
Discipline
Epidemiology
Mathematical modelling
Disease and Health Conditions
HIV/AIDS
Infectious disease
Influenza
Neglected Tropical Diseases (NTDs)
Vector borne disease
Region
Europe & Central Asia (all income levels)
Sub-Saharan Africa (all income levels)

Selected Publications

Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit-risk analysis of health benefits versus excess risk of SARS-CoV-2 infection.
Abbas K; Procter SR; van Zandvoort K; Clark A; Funk S; Mengistu T; Hogan D; Dansereau E; Jit M; Flasche S
2020
The Lancet Global Health
Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study.
Clark A; Jit M; Warren-Gash C; Guthrie B; Wang HHX; Mercer SW; Sanderson C; McKee M; Troeger C; Ong KL
2020
The Lancet. Global Health
Using a real-world network to model localized COVID-19 control strategies.
Firth JA; Hellewell J; Klepac P; Kissler S; CMMID COVID-19 Working Group; Kucharski AJ; Spurgin LG
2020
Nature medicine
Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study.
Kucharski AJ; Klepac P; Conlan AJK; Kissler SM; Tang ML; Fry H; Gog JR; Edmunds WJ; CMMID COVID-19 working group
2020
The Lancet. Infectious diseases
Number of HIV-1 founder variants is determined by the recency of the source partner infection.
Villabona-Arenas CJ; Hall M; Lythgoe KA; Gaffney SG; Regoes RR; Hué S; Atkins KE
2020
SCIENCE
Cost-effectiveness of introducing national seasonal influenza vaccination for adults aged 60 years and above in mainland China: a modelling analysis.
Yang J; Atkins KE; Feng L; Baguelin M; Wu P; Yan H; Lau EHY; Wu JT; Liu Y; Cowling BJ
2020
BMC medicine
See more Publications